Article Details
Retrieved on: 2021-10-30 17:04:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ABOS announced on 7th October 2021 about the dosage of the first patient in Phase 1 clinical Trial of ACU193. ACU193 is a monoclonal antibody that was ...
Article found on: catchingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here